Intermediate-dose Immune Tolerance Induction Outperforms with Faster Success, Less Bleeding and No Added Cost in Comparison with Low-dose: a Multicenter Randomized Clinical Trial
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS（2025）
Key words
immune tolerance induction,intermediate dose,low dose,randomized clinical trial,severe hemophilia A
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined